Anaptysbio, Inc.

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence

Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update